Radhakrishnan Pillai

Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies

Boni E. Elewski, Phoebe Rich, Richard Pollak et al. · Journal of the American Academy of Dermatology · 2012 · 227 citations

Medicine, Dermatology, Pharmacology +17

Comparison of <i>In Vitro</i> Antifungal Activities of Efinaconazole and Currently Available Antifungal Agents against a Variety of Pathogenic Fungi Associated with Onychomycosis

William J. Jo Siu, Yoshiyuki Tatsumi, Hisato Senda et al. · Antimicrobial Agents and Chemotherapy · 2013 · 121 citations · Full text

Life Sciences, Dermatology, Microbiology +17

Mechanism of Action of Efinaconazole, a Novel Triazole Antifungal Agent

Yoshiyuki Tatsumi, Maria Nagashima, Toshiyuki Shibanushi et al. · Antimicrobial Agents and Chemotherapy · 2013 · 106 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

The Low Keratin Affinity of Efinaconazole Contributes to Its Nail Penetration and Fungicidal Activity in Topical Onychomycosis Treatment

Keita Sugiura, Noriaki Sugimoto, Shinya Hosaka et al. · Antimicrobial Agents and Chemotherapy · 2014 · 91 citations · Full text

Medicine, Dermatology, Pharmacology +17

Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials

Linda Stein Gold, Mark Lebwohl, David M. Pariser et al. · Journal of the American Academy of Dermatology · 2018 · 56 citations · Full text

Medicine, Dermatology, Pharmacology +13